drugset / Trial / NCT00326092

A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00326092 ↗

Phase 2 Completed 88 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the comfort of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension

Timeline

Start
2006-05
Primary completion
2006-08
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject brinzolamide/timolol Unknown 0.5 % Topical
Subject brinzolamide/timolol Unknown 1 % Topical